221 related articles for article (PubMed ID: 31083593)
1. Nanoemulsion Based Vehicle for Effective Ocular Delivery of Moxifloxacin Using Experimental Design and Pharmacokinetic Study in Rabbits.
Shah J; Nair AB; Jacob S; Patel RK; Shah H; Shehata TM; Morsy MA
Pharmaceutics; 2019 May; 11(5):. PubMed ID: 31083593
[TBL] [Abstract][Full Text] [Related]
2. Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections.
Nair AB; Shah J; Jacob S; Al-Dhubiab BE; Sreeharsha N; Morsy MA; Gupta S; Attimarad M; Shinu P; Venugopala KN
PLoS One; 2021; 16(3):e0248857. PubMed ID: 33739996
[TBL] [Abstract][Full Text] [Related]
3. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
Patel N; Nakrani H; Raval M; Sheth N
Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
[TBL] [Abstract][Full Text] [Related]
4. Nanoemulsion as a potential ophthalmic delivery system for dorzolamide hydrochloride.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
AAPS PharmSciTech; 2009; 10(3):808-19. PubMed ID: 19536653
[TBL] [Abstract][Full Text] [Related]
5. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
Holland EJ; Lane SS; Kim T; Raizman M; Dunn S
Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
[TBL] [Abstract][Full Text] [Related]
6. Nanocarrier-based topical drug delivery for an antifungal drug.
Hussain A; Samad A; Nazish I; Ahmed FJ
Drug Dev Ind Pharm; 2014 Apr; 40(4):527-41. PubMed ID: 23627443
[TBL] [Abstract][Full Text] [Related]
7. Design of Topical Moxifloxacin Mucoadhesive Nanoemulsion for the Management of Ocular Bacterial Infections.
Youssef AAA; Thakkar R; Senapati S; Joshi PH; Dudhipala N; Majumdar S
Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745818
[TBL] [Abstract][Full Text] [Related]
8. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits.
Tayel SA; El-Nabarawi MA; Tadros MI; Abd-Elsalam WH
Int J Pharm; 2013 Feb; 443(1-2):293-305. PubMed ID: 23333217
[TBL] [Abstract][Full Text] [Related]
9. Preparation, In-vitro, Ex-vivo, and Pharmacokinetic Study of Lasmiditan as Intranasal Nanoemulsion-based In Situ Gel.
Jaber SH; Rajab NA
Pharm Nanotechnol; 2024 Jan; ():. PubMed ID: 38173066
[TBL] [Abstract][Full Text] [Related]
10. Enhanced stability and permeation potential of nanoemulsion containing sefsol-218 oil for topical delivery of amphotericin B.
Hussain A; Samad A; Singh SK; Ahsan MN; Faruk A; Ahmed FJ
Drug Dev Ind Pharm; 2015 May; 41(5):780-90. PubMed ID: 24654936
[TBL] [Abstract][Full Text] [Related]
11. Design of Topical Ocular Ciprofloxacin Nanoemulsion for the Management of Bacterial Keratitis.
Youssef AAA; Cai C; Dudhipala N; Majumdar S
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33802394
[TBL] [Abstract][Full Text] [Related]
12. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans.
McCulley JP; Caudle D; Aronowicz JD; Shine WE
Ophthalmology; 2006 Jun; 113(6):955-9. PubMed ID: 16603244
[TBL] [Abstract][Full Text] [Related]
13. Ocular pharmacokinetics/pharmacodynamics of besifloxacin, moxifloxacin, and gatifloxacin following topical administration to pigmented rabbits.
Proksch JW; Ward KW
J Ocul Pharmacol Ther; 2010 Oct; 26(5):449-58. PubMed ID: 20874668
[TBL] [Abstract][Full Text] [Related]
14. Improved Ocular Bioavailability of Moxifloxacin HCl using PLGA Nanoparticles: Fabrication, Characterization,
Khan FU; Nasir F; Iqbal Z; Neau S; Khan I; Hassan M; Iqbal M; Ullah A; Khan SI; Sakhi M
Iran J Pharm Res; 2021; 20(3):592-608. PubMed ID: 34904011
[TBL] [Abstract][Full Text] [Related]
15. Preparation and
Zhang R; Yang J; Luo Q; Shi J; Xu H; Zhang J
Drug Deliv; 2022 Dec; 29(1):2217-2233. PubMed ID: 35815765
[TBL] [Abstract][Full Text] [Related]
16. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan.
Rajpoot P; Bali V; Pathak K
Int J Pharm; 2012 Apr; 426(1-2):219-230. PubMed ID: 22301424
[TBL] [Abstract][Full Text] [Related]
17. Development of a Luliconazole Nanoemulsion as a Prospective Ophthalmic Delivery System for the Treatment of Fungal Keratitis: In Vitro and In Vivo Evaluation.
Yang J; Liang Z; Lu P; Song F; Zhang Z; Zhou T; Li J; Zhang J
Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297487
[TBL] [Abstract][Full Text] [Related]
18. Aqueous humor penetration of ketorolac formulated in DuraSite or DuraSite 2 delivery systems compared to Acular LS in rabbits.
Shafiee A; Bowman LM; Hou E; Hosseini K
J Ocul Pharmacol Ther; 2013 Nov; 29(9):812-6. PubMed ID: 23992042
[TBL] [Abstract][Full Text] [Related]
19. Nanoemulsion system for the transdermal delivery of a poorly soluble cardiovascular drug.
Dixit N; Kohli K; Baboota S
PDA J Pharm Sci Technol; 2008; 62(1):46-55. PubMed ID: 18402367
[TBL] [Abstract][Full Text] [Related]
20. Enhanced skin permeation of glabridin using eutectic mixture-based nanoemulsion.
Liu C; Hu J; Sui H; Zhao Q; Zhang X; Wang W
Drug Deliv Transl Res; 2017 Apr; 7(2):325-332. PubMed ID: 28188607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
